Cargando…
Coronavirus diseases 2019 and kidney injury: a brief review based on current evidence
Autores principales: | Yang, Guang, Wang, Hao, Liu, Yang, Hou, Jie-Bin, Xu, Guo-Gang, Cao, Feng, Cheng, Qing-Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078429/ https://www.ncbi.nlm.nih.gov/pubmed/33410617 http://dx.doi.org/10.1097/CM9.0000000000001311 |
Ejemplares similares
-
Does the homologous booster with the inactivated coronavirus disease 2019 vaccine work for the omicron variant? Real-world evidence from Jilin, China
por: Guo, Jun, et al.
Publicado: (2023) -
Acute Kidney Injury in the 2019 Novel Coronavirus Disease
por: Qian, Jing-Yi, et al.
Publicado: (2020) -
Famotidine and Coronavirus Disease 2019
por: Freedberg, Daniel E., et al.
Publicado: (2021) -
Pathogenesis of Acute Kidney Injury in Coronavirus Disease 2019
por: Qian, Jing-Yi, et al.
Publicado: (2021) -
Drug-induced Liver Injury With Ritonavir-Boosted Nirmatrelvir: Evidence From Coronavirus Disease 2019 Emergency Use Authorization Adverse Event Reporting System
por: Li, Guo-Fu, et al.
Publicado: (2023)